FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention relates to a compound of formula I or a pharmaceutically acceptable salt thereof, useful in pharmaceutics and medicine:
,
where: R1 is -H, -C(O)R3 or 
, R2 is -H or -C(O)R4; each of R3 and R4 is independently selected from -(C1-C3alkylene)m-(C6-C10aryl), where aryl is unsubstituted or substituted with substituent R5; m is integer 1; R5 is -C1-C6 alkyl.
EFFECT: what is presented is a novel compound, a based pharmaceutical composition and a method thereof, which are effective for treating and preventing HIV infection.
14 cl, 6 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| TRICYCLIC HETEROCYCLIC COMPOUNDS USEFUL AS HIV INTEGRASE INHIBITORS | 2017 |
|
RU2749043C2 |
| ADENOSINE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING SAME | 2020 |
|
RU2824528C2 |
| ANTIVIRAL ALIPHATIC ESTER PRODRUGS OF TENOFOVIR | 2017 |
|
RU2759902C2 |
| PHARMACEUTICAL COMPOUND | 2016 |
|
RU2730842C2 |
| PRODRUGS OF HIV REVERSE TRANSCRIPTASE INHIBITORS | 2015 |
|
RU2693622C2 |
| FUSED TRICYCLIC HETEROCYCLIC COMPOUNDS AS HIV INTEGRASE INHIBITORS | 2016 |
|
RU2740187C2 |
| PYRIDINONE COMPOUNDS AS SELECTIVE CYTOTOXIC AGENTS AGAINST HIV-INFECTED CELLS | 2020 |
|
RU2816090C2 |
| AMINOTETRAHYDROPYRANES AS DIPEPTIDYLPEPTIDASE-IV INHIBITORS FOR TREATING OR PREVENTING DIABETES | 2010 |
|
RU2550508C2 |
| BICYCLIC ARYL MONOBACTAM COMPOUNDS AND METHODS OF USING SAID COMPOUNDS FOR TREATING BACTERIAL INFECTIONS | 2017 |
|
RU2733402C2 |
| NEW SUBSTITUTED N-HYDROXYCARBAMIMIDOYL-1,2,5-OXADIAZOLE COMPOUNDS AS INHIBITORS OF INDOLAMINE-2,3-DIOXYGENASE (IDO) | 2018 |
|
RU2765371C2 |
